Rasistion- and obasky-associated metabolic diseases

被引：149

作者：

Lazar, M. A. ^{[1
]}

机构：

[1] Hosp Univ Penn, Sch Med, Inst Diabet Obes & Metab, Dept Med,Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA

来源：

HORMONE AND METABOLIC RESEARCH | 2007年 / 39卷 / 10期

关键词：

obesity; insulin resistance; resistin; adipokine;

D O I：

10.1055/s-2007-985897

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The link between obesity and diabetes is strong as well as complex. Fat cells produce many circulating regulators of insulin sensitivity, including pro-inflammatory cytokines. In rodents, resistin is produced by adipose tissue, and is a significant regulator of glucose metabolism and insulin sensitivity. In humans, resistin is derived made mainly from macrophages. Given the emerging interrelationship between inflammation and metabolic disease, hyperresistinemia may be a biomarker, and/or a mediator, of metabolic and inflammatory diseases in humans as well as in rodents.

引用

收藏

页码：710 / 716

页数：7

相关论文

共 127 条

[11] Role of fatty acids in the pathogenesis of insulin resistance and NIDDM [J].

Boden, G .

DIABETES, 1997, 46 (01) :3-10

[12] Resistin, an adipokine with potent proinflammatory properties [J].

Bokarewa, M ;

Nagaev, I ;

Dahlberg, L ;

Smith, U ;

Tarkowski, A .

JOURNAL OF IMMUNOLOGY, 2005, 174 (09) :5789-5795

[13] The potential role of resistin in atherogenesis [J].

Burnett, MS ;

Lee, CW ;

Kinnaird, TD ;

Stabile, E ;

Durrani, S ;

Dullum, MK ;

Devaney, JM ;

Fishman, C ;

Stamou, S ;

Canos, D ;

Zbinden, S ;

Clavijo, LC ;

Jang, GJ ;

Andrews, JA ;

Zhu, JH ;

Epstein, SE .

ATHEROSCLEROSIS, 2005, 182 (02) :241-248

[14] Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways [J].

Calabro, P ;

Samudio, I ;

Willerson, JT ;

Yeh, ETH .

CIRCULATION, 2004, 110 (21) :3335-3340

[15] Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones [J].

Chao, L ;

Marcus-Samuels, B ;

Mason, MM ;

Moitra, J ;

Vinson, C ;

Arioglu, E ;

Gavrilova, O ;

Reitman, ML .

JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (10) :1221-1228

[16] PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)-GAMMA - ADIPOSE-PREDOMINANT EXPRESSION AND INDUCTION EARLY IN ADIPOCYTE DIFFERENTIATION [J].

CHAWLA, A ;

SCHWARZ, EJ ;

DIMACULANGAN, DD ;

LAZAR, MA .

ENDOCRINOLOGY, 1994, 135 (02) :798-800

[17] Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters [J].

Chen, CC ;

Li, TC ;

Li, CI ;

Liu, CS ;

Wang, HJ ;

Lin, CC .

METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (04) :471-475

[18] Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans [J].

Cho, YM ;

Youn, BS ;

Chung, SS ;

Kim, KW ;

Lee, HK ;

Yu, KY ;

Park, HJ ;

Shin, HD ;

Park, KS .

DIABETOLOGIA, 2004, 47 (03) :559-565

[19] Regulation of human resistin gene expression in cell systems: an important role of stimulatory protein 1 interaction with a common promoter polymorphic site [J].

Chung, SS ;

Choi, HH ;

Kim, KW ;

Cho, YM ;

Lee, HK ;

Park, KS .

DIABETOLOGIA, 2005, 48 (06) :1150-1158

[20] Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects [J].

Conneely, KN ;

Silander, K ;

Scott, LJ ;

Mohlke, KL ;

Lazaridis, KN ;

Valle, TT ;

Tuomilehto, J ;

Bergman, RN ;

Watanabe, RM ;

Buchanan, TA ;

Collins, FS ;

Boehnke, M .

DIABETOLOGIA, 2004, 47 (10) :1782-1788

← 1 2 3 4 5 6 7 8 9 10 →